Oral medication adherence and disease severity in pediatric inflammatory bowel disease

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 3, 2011, Pages 250-254

  Hommel, Kevin A ^a,b   Denson, Lee A ^a,b   Baldassano, Robert N ^c,d  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

adherence; behavior; disease severity; inflammatory bowel disease

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; CORTICOSTEROID; MESALAZINE;

ADOLESCENT; ARTICLE; BEHAVIOR DISORDER; CHILD BEHAVIOR CHECKLIST; CROHN DISEASE; DEPRESSION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF EVALUATION; SELF REPORT; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADOLESCENT; DEPRESSION; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; PATIENT COMPLIANCE; PREVALENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79951921723     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328344019c     Document Type: Article

References (29)

1. Rapoff MA. Adherence to pediatric medical regimens. New York: Kluwer Academic; 1999.
2. Logan D, Zelikovsky N, Labay L, Spergel J. The illness management survey: identifying adolescents' perceptions of barriers to adherence. J Pediatr Psychol 2003; 28:383-392. (Pubitemid 37034092)
3. Mackner LM, Crandall WV. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2005; 11:1006-1012. (Pubitemid 41580015)
4. Oliva-Hemker MM, Abadom V, Cuffari C, Thompson RE. Nonadherence with thiopurine immunomodulator and mesalamine medications in children with Crohn disease. J Pediatr Gastroenterol Nutr 2007; 44:180-184. (Pubitemid 46175069)
5. Hommel KA, Davis CM, Baldassano RN. Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2009; 15:589-593.
6. Hommel KA, Denson LA, Crandall W, Mackner LM. Behavioral functioning and treatment adherence in pediatric inflammatory bowel disease: review and recommendations for practice. Eur J Gastroenterol Hepatol 2008; 4:785-791.
7. Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003; 114:39-43. (Pubitemid 36126514)
8. Modi AC, Quittner AL. Barriers to treatment adherence for children with cystic fibrosis and asthma: What gets in the way? J Pediatr Psychol 2006; 31:846-858. (Pubitemid 44310212)
9. Witherspoon D, Drotar D. Correlates of adherence to prophylactic penicillin therapy in children with sickle cell disease. Children's Health Care 2006; 35:281-296. (Pubitemid 44893981)
10. Ingerski LM, Baldassano RN, Denson LA, Hommel KA. Barriers to oral medication adherence for adolescents with inflammatory bowel disease. J Pediatr Psychol 2010; 35:683-691.
11. Hommel KA, Baldassano RN. Brief report: barriers to treatment adherence in pediatric inflammatory bowel disease. J Pediatr Psychol 2010; 35:1005-1010.
12. Kovacs M, Goldston D, Obrosky DS, Iyengar S. Prevalence and predictors of pervasive noncompliance with medical treatment among youths with insulin-dependent diabetes mellitus. J Am Acad Child Adolesc Psychiatry 1992; 31:1112-1119.
13. La Greca AM, Follansbee D, Skyler JS. Developmental and behavioral aspects of diabetes management in youngsters. Children's Health Care 1990; 19:132-137.
14. Anderson BJ, Auslander WF, Jung KC, Miller JP, Santiago JV. Assessing family sharing of diabetes responsibilities. J Pediatr Psychol 1990; 15:477-492. (Pubitemid 20366295)
15. Jacobson AM, Hauser ST, Lavori P, Wolfsdorf JI, Herskowitz RD, Milley JE, et al. Adherence among children and adolescents with insulin-dependent diabetes mellitus over a four-year longitudinal follow-up: I. The influence of patient coping and adjustment. J Pediatr Psychol 1990; 15:511-526. (Pubitemid 20366297)
16. Brownbridge G, Fielding DM. Psychosocial adjustment and adherence to dialysis treatment regimes. Pediatr Nephrol 1994; 8:744-749.
17. Zelikovsky N, Schast AP. Eliciting accurate reports of adherence in a clinical interview: development of the medical adherence measure. Pediatr Nurs 2008; 34:141-146.
18. Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991; 12:439-447.
19. Hyams J, Markowitz J, Otley A, Rosh J, Mack D, Bousvaros A, et al. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 2005; 41:416-421. (Pubitemid 41407602)
20. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330:1841-1845. (Pubitemid 24188135)
21. Fanjiang G, Russell GH, Katz AJ. Short- and long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr 2007; 44:312-317. (Pubitemid 46673377)
22. Achenbach TM, Rescorla LA. Manual for the ASEBA school-age forms and profiles. Burlington, VT University of Vermont: Research Center for Children, Youth, & Families; 2001.
23. Kovacs M. Children's depression inventory. North Tonawanda, NY: Multi-Health Systems; 1992.
24. Hommel KA, Mackner LM, Denson LA, Crandall WV. Treatment regimen adherence in pediatric gastroenterology. J Pediatr Gastroeneterol Nutr 2008; 47:526-543.
25. Pinquart M, Shen Y. Depressive symptoms in children and adolescents with chronic physical illness: an updated meta-analysis. J Pediatr Psychol 2010. Advance Access.
26. Greenley RN, Cunningham C. Parent quality of life in the context of pediatric inflammatory bowel disease. J Pediatr Psychol 2009; 34:129-136.
27. Blanchard JF, Bernstein CN, Wajda A, Rawsthorne P. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001;154:328-335. (Pubitemid 32756629)
28. Mackner LM, Crandall WV. Long-term psychosocial outcomes reported by children and adolescents with inflammatory bowel disease. Am J Gastroenterol 2005; 100:1386-1392. (Pubitemid 40904367)
29. Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, Uusoue K, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007; 133:423-432. (Pubitemid 47193130)